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emergency depatiments. An ability to use a personal computer (PC) and
nonproprietary software/hardware would be convenient and cost-effective.
To determine interpretive concordance from a remote-site PC, 2 blinded ob-
servers re-scored 26 consecutive TI-201 studies that had been previously
interpreted in our lab. SPECT and planar (anterior and LAO-459 views)
images were modem transferred to an Internet Web page. Images were
displayed in standard format using an 8 bit grey scale, 1 mb video card, 800
x 600 resolution, 17” monitor, and a Pentium 100 mHz computer. Quality
was judged adequate-high for all studies. Descriptive data: 68% male, 76%
known CAD, 52% prior Ml, 32% prior CABG, 68% prior PTCA, 52% exercise
stress. Results (all p = ns) (MVD = multivessel CAD).
Normal Ischemia
Any MVD LAD RCA LCX
NuclLab 7 18 11 11 13 10
RemotePC 8 17 10 12 12 10
Byindividual pt, concordances foranyabnormality, for MVD, and vascular
territory of abnormality were 83Y0,61%, and 85% respectively. Conclusion:
This study of relatively complex scans establishes the clinical feasibility of
interpretation using the Internet and a generic display configuration. Fur-
ther studies are indicated to determine whether additional data or different
hardware may improve results.
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m The(R)-and(s)-~nan~iom~r~ofBeti-B1ockersAreDifferentDrugs
K.Stoschitzky,W. Lindner 1, W. Klein. Department of Medicine/Division of
Cardiology, Graz, Austria, 1 Institute of Pharmaceutical C/rernist~, Karl
Franzens University Graz, Austria
In order to investigate the clinical impact of chirality in beta-blocking drugs,
we performed two randomized, double-blind, cross-over studies with two
groups of 12 healthy volunteers who received single oral doses of 40 mg
(R)- and 40 mg (S)-propranoiol, or 50 mg (R)- and 50 mg (S)-atenolol,
respectively, at intervals of 1 week. Exercise was performed prior to and
4 hours after drug intake, blood samples were taken immediately before
and after exercise. Compared with baseline, heart rate during exercise was
reduced by (S)-propranoiol (-22%, p < 0.001) and (S)-atenolol (–25%, p c
0.001) whereas the (R)-enantiomers had no effect. At rest, the mean plasma
concentration of (S)-propranolol was higher (+26%, p < 0.001) than that of
(R)-propranolol, whereas that of (S)-atenolol was lower (–3%, p < 0.01) than
that of (R)-atenolol. Exercise caused an increase of plasma concentrations
of (S)-propranolol (+25%, p < 0.001) and (S)-atenolol (+44%, p < 0.001)
whereas those of the (R)-enantiomers remained unaffected.
These date demonstrate profound and clinically significant, pharma-
codynamic and pharmaookinetic differences between the (R)- and (S)-
enantiomers of propranolol as well aa those of atenolol. Therefore, we
suggest that the (R)- and (S)-enantiomerS of beta-blocking drugs should
be recognized and used as individual drugs by themselves rather than just
as “the enantiomem” of racemic drugs. According to the present state of
the art, the currently used racemic mixtures should no longer be regarded
as the best possible remedies in beta-blocker therapy, they rather,should
be replaced by the optically pure (S)-enantiomers which can nowadays be
provided easily and at low costs.
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Oxidized low density lipoprotein (LDL) taken up by macrophages via the
scavenger receptor may contribute to formation of intimal foam ceils. We
have previously reporb?dthat several fl-blockeragents have variable degrees
of antioxidant potency on LDL. Moreover, previous studies have shown that
p-blocker agents reduce experimental atherosclerosis in primates. Thus,
in this study we investigated whether fl-blceker agents may prevent LDL
cholesteyl esterification induced by oxygen radicals, a key event in foam cell
formation. Purified human LDL were exposed to oxygen radicals generatad
by CUS04 (15 MMfor 20 hours at 37~C)under control conditions, or after a
30 minute pre-incubation with the p-blocker agent propranolol, metoprolol,
and acebutolol (1 and 3 KM of concentration).
p-Blocker Propranolol Metoprolol Acebutolol
Dose (uM) 1 3 1 3 1 3
MDA (4Areduction) –35* -57” –22 –42* –20 –43”
CE (ControlOXLDL54 + 3) 28+ 2“ 14 +2* 34 + 2 19 + 2* 38 + 2 22 +2*
Legend.MDA: malondialdehyde;CE: cholesterolesters (nmolfmgcell proteirV12hs). * p
<0,05 w relativecontrols.
Ourdatademonstrate that j?-blockeragents exert a decrease on choleateryl
esterification formation. These results were achieved with concentrations of
potentially clinically use. Although these drugs are known to adversely af-
fect lipid metabolism, inhibition of both oxidative compounds and cholesterol
esterification may reduce uptake of oxidized LDL and hence foam cell for-
mation.
I 1027-I75I Nipracfilol,aNitricOxidaReleasing
Beta-BlockingAgent,Reversesthe Severityof
MyocardialInjuryaftarlschemia-Reperfusioni
Cholesterol-FedRabbits
J. Igarashi, S. Hoshida, M. Nishida, N. Yamashita, K. Aoki, M. Hori,
T. Kuzuya, M. Tada. Osaka University Medical School, Suita, Japan
3,4-Dihydro-8-(2-hydroW-3-isopropylamino)-propoxy-3-nitroxy-2H-l-benzopyran
(nipradilol) was designed to cancel the action of beta-adrenergic blockers on
vasculature by adding nitroxy residue to beta-blocker structure. We studied
the effects of chronic treatment with nipradilol (10 mgfkg/day) on the size of
infarct resulting from corona~ occlusion (30 rein) - reperfusion (48 h) in rab-
bits fed with/without 1% cholesterol for 10weeks. Propranolol (50 mg/k@day)
was used as a control. Infarct size in cholesterol-fed rabbits (69.9 + 3.8Y0,
n = 10) was significantly larger than that in noncholesterol-fed rabbits (48.8
+ 5.8%, n =9, p < 0.05). The augmentation of infarct size in cholesterol-fed
rabbits was markedly reversed by nipradilol (49.2 + 6.4%, n = 9, p < 0.05),
but not by propranolol (54.9 + 6.3%, n =9, n.s.). In noncholesterol-fsd rab-
bits, neither nipradilol nor propranolol affected the infarct size (52.5 + 4.6%
and 61.9 + 7.2%, respectively, n.S.). There were no significant differences
in the area at risk and in hemodynamic data during the course of experi-
ment among all groups. Acetylcholine (10-5 M)-induced relaxation of aorta
was markedly impaired in cholesterol-fed rabbits (57 & 5 vs. 95 * 4%, p c
0.05), which was completely reversed by nipradilol (96 + 5%, p c 0.05). We
also studied whether or not nipradilol releases nitric oxide (NO) in smooth
muscle cells. When cultures of rat aortic smooth muscle cells were treated
with nipradilol (0.5 mM), nitrite concentration in the culture media significantly
increased from 0.0 + 0.3 to 36.0 + 0.9 nmol/mg prot (p < 0.05), resulting in
marked increase in cGMP content. These results demonstrate that chronic
treatment with nipradilol of atherosclerotic animals could reverae the severity
of myooardial injury after ischemia-reperfusion. These beneficial effects of
nipradilol upon myocardial injury might be associated with its potency ae a
NO releasing agent.
11027-1761 AntihypetlensiveandVaSCUlarEffeCtSOf
ETA-ReceptorBlockadein DahlSalt-Sensitive
Hypertension
L.V.d’Uscio, P.Moreau, M. Batton, T.F.Luscher. Cardiobg~ Cardiovascular
Research, University Hospital, Bern, Switzerland
The involvementof endothelin(ET) in hypertensionis still unclear.Our
objectivewas to determinethe effectof a new,orally available,selective
ETA-receptorantagonist,LU135252,on the bloodpressureelevationand
the changesof vascularstructurein a modelof salt-inducedhypertension.
Dahlsalt-sensitive(DS)and Dahlsalt-resistantrats(DR)weretreatedfor 8
weekswith4Y.NaClaloneor in combinationwithLU135252(60m@g/day
in the chow).Placebo-treatedratsservedas controls(n = 6-6/group).The
basilaranda smallmesentericartery(lumendiameterof 200and250-300
ym, respectively)were isolatedand their geomet~ studiedin vitro under
perfusedand pressurizedconditions.Chronicsaltadministrationincreased
systolicbloodpressureby37 + 3 mmHgin DSrats,as comparedto 1 + 2
mmHgin controlDS rats(p < 0.05;tail cuffmethod).This increasewas in
partpreventedby concomitantLU135252administration(19 + 3 mmHg;p
<0.05 vs salt-treatedDSrats).The meditilumenratioof the basilarartery
increasedin theDSratson4% NaCl diet by eutrophic remodeling; vascular
